论文部分内容阅读
目的:探讨影响肺癌脑转移综合治疗的预后因素及提高生存质量的可能性。方法:1990 年3月~1995 年3 月间对65 例肺癌脑转移患者行单纯放疗及手术切除加放疗。放疗( 全脑) 分为2 组:常规放疗剂量22 ~40 Gy/2 .2 ~4w ,后缩野追加15 ~20 Gy/1 .5 ~2w ;全脑快速照射剂量18 ~24 Gy/11 ~15w ,后缩野追加15 ~20 Gy/15 ~20w 。结果:手术切除加放疗的中位生存期95 个月和1 年生存率623 % ,显著优于单放组的55 个月和145 % ( P< 005) 。全脑快速照射能迅速缓解症状,未能提高生存率。结论:肺癌脑转移采用手术加放疗的疗效比单纯放疗好。
Objective: To explore the prognostic factors affecting the comprehensive treatment of brain metastases of lung cancer and the possibility of improving the quality of life. Methods: From March 1990 to March 1995, 65 patients with brain metastases of lung cancer underwent radiotherapy and surgical resection plus radiotherapy. Radiotherapy (whole brain) is divided into two groups: conventional radiotherapy dose 22 ~ 40 Gy / 2. 2 ~ 4w, after shrinkage additional 15 ~ 20 Gy / 1. 5 ~ 2w; whole brain rapid irradiation dose 18 ~ 24 Gy / 1 1 ~ 1 5w, after shrinkage additional 15 ~ 20 Gy / 1 5 ~ 2 0w. Results: The median survival time of surgical resection plus radiotherapy was 9.5 months and the one-year survival rate was 623%, which was significantly better than that of 5 ± 5 months and 145% (P <005) . Rapid whole brain irradiation can quickly relieve symptoms, failed to improve the survival rate. Conclusion: The efficacy of surgery plus radiotherapy for brain metastases of lung cancer is better than radiotherapy alone.